133 related articles for article (PubMed ID: 10635999)
1. Molecular spectra of HPRT deletion mutations in circulating T-lymphocytes in Fanconi anemia patients.
Laquerbe A; Sala-Trepat M; Vives C; Escarceller M; Papadopoulo D
Mutat Res; 1999 Dec; 431(2):341-50. PubMed ID: 10635999
[TBL] [Abstract][Full Text] [Related]
2. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia.
Smith J; Andrau JC; Kallenbach S; Laquerbe A; Doyen N; Papadopoulo D
J Mol Biol; 1998 Sep; 281(5):815-25. PubMed ID: 9719637
[TBL] [Abstract][Full Text] [Related]
3. Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.
Sala-Trepat M; Boyse J; Richard P; Papadopoulo D; Moustacchi E
Mutat Res; 1993 Sep; 289(1):115-26. PubMed ID: 7689157
[TBL] [Abstract][Full Text] [Related]
4. The molecular mechanism underlying formation of deletions in Fanconi anemia cells may involve a site-specific recombination.
Laquerbe A; Moustacchi E; Fuscoe JC; Papadopoulo D
Proc Natl Acad Sci U S A; 1995 Jan; 92(3):831-5. PubMed ID: 7846061
[TBL] [Abstract][Full Text] [Related]
5. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of spontaneously occurring mutations in the HPRT gene of the Chinese hamster V79 cell mutant V-H4, which is homologous to Fanconi anemia group A.
Telleman P; Overkamp WJ; Zdzienicka MZ
Mutagenesis; 1996 Mar; 11(2):155-9. PubMed ID: 8671732
[TBL] [Abstract][Full Text] [Related]
7. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
Yoshioka M; O'Neill JP; Vacek PM; Finette BA
Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
[TBL] [Abstract][Full Text] [Related]
8. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
[TBL] [Abstract][Full Text] [Related]
9. Quantification of illegitimate V(D)J recombinase-mediated mutations in lymphocytes of newborns and adults.
Scheerer JB; Xi L; Knapp GW; Setzer RW; Bigbee WL; Fuscoe JC
Mutat Res; 1999 Dec; 431(2):291-303. PubMed ID: 10635995
[TBL] [Abstract][Full Text] [Related]
10. Quantification of hprt gene deletions mediated by illegitimate V(D)J recombination in peripheral blood cells of humans.
Fuscoe JC; Vira LK; Collard DD; Moore MM
Environ Mol Mutagen; 1997; 29(1):28-35. PubMed ID: 9020304
[TBL] [Abstract][Full Text] [Related]
11. The fidelity of double strand breaks processing is impaired in complementation groups B and D of Fanconi anemia, a genetic instability syndrome.
Escarceller M; Rousset S; Moustacchi E; Papadopoulo D
Somat Cell Mol Genet; 1997 Nov; 23(6):401-11. PubMed ID: 9661703
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia C gene product plays a role in the fidelity of blunt DNA end-joining.
Escarceller M; Buchwald M; Singleton BK; Jeggo PA; Jackson SP; Moustacchi E; Papadopoulo D
J Mol Biol; 1998 Jun; 279(2):375-85. PubMed ID: 9642044
[TBL] [Abstract][Full Text] [Related]
13. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans.
Fuscoe JC; Zimmerman LJ; Harrington-Brock K; Burnette L; Moore MM; Nicklas JA; O'Neill JP; Albertini RJ
Mutat Res; 1992 Sep; 283(1):13-20. PubMed ID: 1380658
[TBL] [Abstract][Full Text] [Related]
14. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.
Fuscoe JC; Zimmerman LJ; Lippert MJ; Nicklas JA; O'Neill JP; Albertini RJ
Cancer Res; 1991 Nov; 51(21):6001-5. PubMed ID: 1933863
[TBL] [Abstract][Full Text] [Related]
15. Mutagenic processing of psoralen monoadducts differ in normal and Fanconi anemia cells.
Guillouf C; Laquerbe A; Moustacchi E; Papadopoulo D
Mutagenesis; 1993 Jul; 8(4):355-61. PubMed ID: 8377656
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of three novel Fanconi anemia mutations in Israeli Arabs.
Tamary H; Dgany O; Toledano H; Shalev Z; Krasnov T; Shalmon L; Schechter T; Bercovich D; Attias D; Laor R; Koren A; Yaniv I
Eur J Haematol; 2004 May; 72(5):330-5. PubMed ID: 15059067
[TBL] [Abstract][Full Text] [Related]
17. The Fanconi anemia pathway limits the severity of mutagenesis.
Hinz JM; Nham PB; Salazar EP; Thompson LH
DNA Repair (Amst); 2006 Aug; 5(8):875-84. PubMed ID: 16815103
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.
Flynn EK; Kamat A; Lach FP; Donovan FX; Kimble DC; Narisu N; Sanborn E; Boulad F; Davies SM; Gillio AP; Harris RE; MacMillan ML; Wagner JE; Smogorzewska A; Auerbach AD; Ostrander EA; Chandrasekharappa SC
Hum Mutat; 2014 Nov; 35(11):1342-53. PubMed ID: 25168418
[TBL] [Abstract][Full Text] [Related]
19. Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus.
Papadopoulo D; Guillouf C; Mohrenweiser H; Moustacchi E
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8383-7. PubMed ID: 2236046
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel mutations of the major Fanconi anemia gene FANCA in the Japanese population.
Yagasaki H; Hamanoue S; Oda T; Nakahata T; Asano S; Yamashita T
Hum Mutat; 2004 Dec; 24(6):481-90. PubMed ID: 15523645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
